<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="ijerph-17-05904-t005" orientation="portrait" position="float">
 <object-id pub-id-type="pii">ijerph-17-05904-t005_Table 5</object-id>
 <label>Table 5</label>
 <caption>
  <p>Potential therapeutics against SARS-CoV-2 (COVID-19) [
   <xref rid="B68-ijerph-17-05904" ref-type="bibr">68</xref>,
   <xref rid="B105-ijerph-17-05904" ref-type="bibr">105</xref>,
   <xref rid="B112-ijerph-17-05904" ref-type="bibr">112</xref>,
   <xref rid="B116-ijerph-17-05904" ref-type="bibr">116</xref>,
   <xref rid="B125-ijerph-17-05904" ref-type="bibr">125</xref>,
   <xref rid="B126-ijerph-17-05904" ref-type="bibr">126</xref>,
   <xref rid="B127-ijerph-17-05904" ref-type="bibr">127</xref>,
   <xref rid="B128-ijerph-17-05904" ref-type="bibr">128</xref>,
   <xref rid="B129-ijerph-17-05904" ref-type="bibr">129</xref>,
   <xref rid="B130-ijerph-17-05904" ref-type="bibr">130</xref>]. IFNs, interferons.
  </p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Drug</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Type</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Mechanism</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Recommendation</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">Remdesivir</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Antiviral</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Remdesivir targets the viral RNA polymerases to inhibit the replication of the virus, previously used for Ebola</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Clinical trials have been conducted</td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">Favipiravir</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Antiviral</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Favipiravir interacts with viral RNA polymerase, thus inhibiting viral replication</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Efficacy has been proven</td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">Convalescent plasma</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Antiviral</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Convalescent plasma obtained from the cured ones provides protective antibodies against SARS-CoV-2</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Clinical trials have been conducted</td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">Chloroquine Hydroxychloroquine</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Anti-malaria</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Inhibition of endosomal acidified fusion and also have an anti-inflammatory effect</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Efficacy has been proven</td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">IFNs</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Immuno-enhancer</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">IFNs interfere with the viral RNA transcription and translation of protein, and thus inhibit viral replication</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Clinical trials have been conducted, and efficacy has been proven</td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">Lopinavir/ritonavir</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Antiviral </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">It inhibits the protease enzyme, thereby preventing the cleavage of polyproteins, and it produces immature particles.</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Clinical trials underway</td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">Corticosteroids</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Corticosteroids</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Corticosteroids diminish pro-inflammatory cytokines and show an anti-fibrotic property</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Controversial state</td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">Dexamethasone</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Glucocorticoids</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Dexamethasone inhibits the protective function of T cells and reduces the ability of B cells to synthesize antibodies, as well as limits the damaging effects of cytokines</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Clinical trials underway</td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">Vitamin C</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Nutritional supportive management</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Vitamin C strengthens the immunity response by increasing IFN production and enhancing the capability of phagocytosis by neutrophils</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Clinical trials have been conducted</td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">Zinc</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Nutritional supportive management</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Zinc is mandatory for the efficient activity of the immune system and also has antiviral property, as it also enhances the therapeutic activity of hydroxychloroquine</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Clinical trials have been conducted</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Enoxaparin</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Low molecular weight heparin (LMWH), anticoagulant</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Enoxaparin showed its anticoagulant activity and is used in thromboprophylaxis in COVID-19 patients</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinical trials underway</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
